noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Celcuity Inc.

A randomized phase II non comparative study of PF 04691502 and[...]
Celcuity Inc.

Subgroup of HER2-negative breast cancer patients with hyperactive RAS[...]
Celcuity Inc.

Phase I dose escalation study of the dual PI3K mTORC1/2 inhibitor[...]

Healthcare

Celcuity Inc.

12/08/2023 | Press release | Archived content

Subgroup of ovarian cancer patients with hyperactive RAS network signaling identified: dynamic pathway activity test identifies patients that may benefit from PI3K/mTOR or[...]

Sharing and Personal Tools

Please select the service you want to use: